H
Hana Joch
Researcher at University of Zurich
Publications - 11
Citations - 1400
Hana Joch is an academic researcher from University of Zurich. The author has contributed to research in topics: Endothelium & Endothelial stem cell. The author has an hindex of 9, co-authored 11 publications receiving 1363 citations.
Papers
More filters
Journal ArticleDOI
High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells Role of Protein Kinase C and Reactive Oxygen Species
Francesco Cosentino,Masato Eto,Paola De Paolis,Bernd van der Loo,Markus Bachschmid,Volker Ullrich,Alexei Kouroedov,Chiara Delli Gatti,Hana Joch,Massimo Volpe,Thomas F. Lüscher +10 more
TL;DR: High glucose, via PKC signaling, induces oxidative stress and upregulation of COX-2, resulting in reduced NO availability and altered prostanoid profile.
Journal ArticleDOI
Statin Prevents Tissue Factor Expression in Human Endothelial Cells Role of Rho/Rho-Kinase and Akt Pathways
TL;DR: Endothelial tissue factor induction by thrombin is regulated by Rho/Rho-kinase, Akt, and p38 MAP kinase, which provides new insights into the action of statins in acute coronary syndromes.
Journal ArticleDOI
Thrombin Suppresses Endothelial Nitric Oxide Synthase and Upregulates Endothelin-Converting Enzyme-1 Expression by Distinct Pathways: Role of Rho/ROCK and Mitogen-Activated Protein Kinase
Masato Eto,Christine Barandier,Lisa Rathgeb,Toshiyuki Kozai,Hana Joch,Zhihong Yang,Thomas F. Lüscher +6 more
TL;DR: Thrombin suppresses eNOS and upregulates ECE-1 expression via Rho/ROCK and ERK pathway, respectively, and may be important for endothelial dysfunction in cardiovascular disease, particularly during acute coronary episodes.
Journal ArticleDOI
Cell-Type-Specific Characteristics Modulate the Transduction Efficiency of Adeno-Associated Virus Type 2 and Restrain Infection of Endothelial Cells
Katri Pajusola,Marcin Gruchała,Hana Joch,Thomas F. Lüscher,Seppo Ylä-Herttuala,Hansruedi Büeler +5 more
TL;DR: Analysis of the efficiencies of transduction and the transport mechanisms of AAV type 2 (AAV-2) in different cell types, emphasizing endothelial cells, points to a more complex cell-type-specific mode ofTransduction of Aav-2 than previously appreciated.
Journal ArticleDOI
Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
Christian M. Matter,Izabela Rozenberg,Andrea Jaschko,Helen Greutert,David J. Kurz,Stephan Wnendt,Bernd Kuttler,Hana Joch,Jürg Grünenfelder,Gregor Zünd,Felix C. Tanner,Thomas F. Lüscher +11 more
TL;DR: Tacrolimus is less potent than sirolimus for inhibiting VSMC proliferation or migration, but exerts markedly less antiproliferative effects on EC compared with sIROlimus, and may represent a promising compound for the use in drug-eluting stents.